You are here

Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease

Last updated on February 28, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Aventura, Florida, 33180 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Parkinson's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
30-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female subjects with a diagnosis of idiopathic Parkinson's disease.

- Daily L-dopa dose between 300 and 1200 mg.

- MBRS score >1.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Surgical intervention for Parkinson's disease.

- History of troublesome dyskinesias.

- Any significant AXIS I psychiatric disease.

NCT02006290
Pfizer
Completed
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now